Delivery Order SPE2DB22D3009-SPE2DB25FAY08
Award Date
5/27/25
Potential Completion Date
5/28/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 510 mg/17 mL vials of the pharmaceutical product Ferumoxytol, with a ceiling value of $2,434.84 and a period of performance through May 29, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a medical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,655.48 and a performance period ending on June 11, 2025. The contract is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp also...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ferumoxytol 510 mg/17 ml vials. The total ceiling value of the order is $11,582.66, with a firm fixed-price contract type and an ultimate completion date of May 9, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 510 mg/17 ml vials of the pharmaceutical drug ferumoxytol, valued at $6,484.80. The contract has an ultimate completion date of April 9, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB22D2007|SPE2DB25FJ1GW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,172,431 units of the pharmaceutical product Ferumoxytol 510 mg/17 ml vial, 17 ml, with a ceiling value of $3,996.92. The contract is a Firm Fixed Price Delivery Order, with a performance period through May 8, 2025. This award is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,966.41 delivery order is for the supply of 510 mg/17 mL vials of the drug ferumoxytol. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $2,161.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ferumoxytol 510 mg/17 ml vial, a pharmaceutical product, with a performance period extending to April 2025. The contract is a Firm Fixed Price Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, held by...
This federal contract award is for the delivery of Ferumoxytol, a 510 mg/17 ml vial, to the Defense Logistics Agency (DLA). The $3,724.60 firm fixed price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Ferumoxytol 510 mg/17 ml vials. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $3,351.60 and a period of performance through February 21, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,214.82, is a delivery order for the supply of Ferumoxytol 510 mg/17 ml vial, a medical product used for various therapeutic applications. The contract has a firm fixed-price pricing type and a completion date of November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery...